A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
Kimberley Steele, M.D., Ph.D., ARPA-H Program Manager, will join the Investor Catalyst Hub’s April member meeting to discuss the importance of lymphatics in health. Dr. Steele, an internationally recognized expert […]
Join us for our first joint members-only meeting hosted by the Customer Experience Hub and Investor Catalyst Hub. You will gain a comprehensive overview of the ARPANET-H network, its remarkable capabilities, and the many benefits it offers to our valued members.
The Investor Catalyst Hub is excited to feature a diverse panel of representatives from investor and venture capital spoke organizations at our May member meeting. With a focus on health […]
ARPA-H Program Manager Paul E. Sheehan, Ph.D., will join the Investor Catalyst Hub’s virtual monthly meeting to discuss the various programs in his portfolio.
Spokes are invited to join an exclusive virtual networking session that will feature three breakout rooms.
This conversation will be about Cancer Moonshot goals, current investments in cancer, and engagement with ARPA-H.
The MassMEDIC Member Mixer is a fun and entertaining way to engage with your fellow industry leaders and make new business contacts!
Join the Investor Catalyst Hub to hear from a panel of spoke organizations working within digital health.
Kimberley Steele, M.D., Ph.D., ARPA-H Program Manager, will join the Investor Catalyst Hub and Customer Experience Hub for an information session to discuss ARPA-H’s new Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) program.
Learn more about what investors and venture capital firms look for when considering new investment opportunities in health care.
Tune in to a fireside chat with spoke members on the impact of artificial intelligence on health innovation.
Tune in to a fireside chat with ARPA-H Program Manager Dr. Calvin Roberts to learn more about ARPA-H’s new OCULAB program.